These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Martin R; McFarland HF Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789 [TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Holmøy T; Hestvik AL Curr Opin Infect Dis; 2008 Jun; 21(3):271-8. PubMed ID: 18448972 [TBL] [Abstract][Full Text] [Related]
4. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis. Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225 [TBL] [Abstract][Full Text] [Related]
5. The immunopathogenesis of multiple sclerosis. Giovannoni G Baillieres Clin Neurol; 1997 Oct; 6(3):387-407. PubMed ID: 10101580 [TBL] [Abstract][Full Text] [Related]
6. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. Sellner J; Kraus J; Awad A; Milo R; Hemmer B; Stüve O Autoimmun Rev; 2011 Jun; 10(8):495-502. PubMed ID: 21354338 [TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of multiple sclerosis. Work-hypotheses and experimental data]. Neu I Fortschr Med; 1977 Mar; 95(9):535-8. PubMed ID: 844779 [TBL] [Abstract][Full Text] [Related]
9. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy. Kieseier BC; Archelos JJ; Storch M; Gold R; Hartung HP Wien Klin Wochenschr; 1999 Sep; 111(17):728-37. PubMed ID: 10526397 [TBL] [Abstract][Full Text] [Related]
10. Contribution of peptides to multiple sclerosis research. Alcaro MC; Papini AM Biopolymers; 2006; 84(4):349-67. PubMed ID: 16518843 [TBL] [Abstract][Full Text] [Related]
11. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182 [TBL] [Abstract][Full Text] [Related]
12. [Genetic susceptibility to multiple sclerosis (MS). INSERM Network of Clinical Research on the Genetic Susceptibility to MS]. Fontaine B Rev Neurol (Paris); 1998 Sep; 154(8-9):601-5. PubMed ID: 9809375 [TBL] [Abstract][Full Text] [Related]
13. [Multiple sclerosis: epidemiology, molecular pathology and therapy]. Steck AJ; Schaeren-Wiemers N Schweiz Med Wochenschr; 1999 Nov; 129(46):1764-8. PubMed ID: 10603650 [TBL] [Abstract][Full Text] [Related]
14. [Multiple sclerosis--an immunological disease]. Vedeler CA Tidsskr Nor Laegeforen; 1991 Mar; 111(8):944-7. PubMed ID: 2042210 [TBL] [Abstract][Full Text] [Related]
16. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis]. Rodríguez-Rodríguez Y; Suárez-Luis I Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047 [TBL] [Abstract][Full Text] [Related]
17. [Recent progress in treatment for multiple sclerosis]. Kira J Rinsho Shinkeigaku; 2000 Dec; 40(12):1261-3. PubMed ID: 11464473 [TBL] [Abstract][Full Text] [Related]
18. The genetic epidemiology of multiple sclerosis. Compston A Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1623-34. PubMed ID: 10603615 [TBL] [Abstract][Full Text] [Related]
19. [New approaches in research of therapy of multiple sclerosis]. Hemmer B; Cepok S; Nessler S; Sommer N Med Klin (Munich); 2001 Sep; 96 Suppl 1():23-8. PubMed ID: 11603112 [TBL] [Abstract][Full Text] [Related]
20. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology? Johnson AJ; Suidan GL; McDole J; Pirko I Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]